GALNT4 and neoplasm: Liu et al. demonstrated that the polypeptide N-acetylgalactosaminyltransferase GALNT4 promoted the development of cancer as a tumour suppressor gene, and the level of expression could act as an independent favourable prognostic factor for recurrence-free survival (RFS) and OS (Liu Y. et al., 2017).